Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 ...

New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of ...

Scientists from the UK, Japan, and France have developed a non-toxic alternative to harmful PFAS chemicals by replicating fluorine’s unique “bulkiness” using only carbon and hydrogen. This ...

Background: Early identification and diagnosis are pivotal in the management of patients with acute myocardial infarction (AMI ... cross-sectional analysis of 874 STEMI (234 females and 640 males) and ...

New‐onset atrial fibrillation (NOAF) is a common complication after acute myocardial infarction (AMI ... age (<75 versus ≥75 years), sex (male versus female), STEMI versus non‐STEMI, undergoing ...

It included all cases of ST elevation myocardial infarction (STEMI) requiring urgent catheterisation ... parametric variables as means±SD and non-parametric variables as medians and IQR. We further ...

The fundamental care quality indicators for ST-segment elevation myocardial infarction (STEMI) treatment remained unchanged. Following the European Society of Cardiology (ESC), adequate indicators of ...

Introduction: Development of hemoglobin-based oxygen carriers (HBOCs) for use as temporary blood replacement solutions and treatment of hemorrhagic shock has been hindered because of evidence HBOC ...